Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

《2020年中国心脏骤停后脑保护专家共识》解读一 神经功能评估

2021-08-20 中华脑血管病杂志(电子版)

心脏骤停神经保护

对于心脏骤停患者，复苏后神经功能评估至关重要。准确的神经功能评估可以避免对于有脑复苏可能患者的过早或不恰当撤除生命支持手段而导致的不必要的死亡，也有助于早期识别无脑复苏希望的患者。

中文标题：

《2020年中国心脏骤停后脑保护专家共识》解读一 神经功能评估

发布机构：

发布日期：

2021-08-20

简要介绍：

对于心脏骤停患者，复苏后神经功能评估至关重要。准确的神经功能评估可以避免对于有脑复苏可能患者的过早或不恰当撤除生命支持手段而导致的不必要的死亡，也有助于早期识别无脑复苏希望的患者。我国心脏骤停后诊疗仍然存在诸多不足，如医务人员对复苏后神经功能评估的认知度低、实践情况不规范等。为了提高院前急救、急诊科以及危重症医师对于心脏骤停后神经功能评估的认知度，推进规范化神经功能评估操作流程，本文就《2020 年中国心脏骤停后脑保护专家共识》中的神经功能评估部分进行解读，内容主要涉及心肺复苏后神经功能评估的手段和流程。

相关资料下载：
[AttachmentFileName(sort=1, fileName=《2020年中国心脏骤停后脑保护专家共识》解读一神经功能评估.pdf)] GetToolGuiderByIdResponse(projectId=1, id=15b8e1c002302595, title=《2020年中国心脏骤停后脑保护专家共识》解读一 神经功能评估, enTitle=, guiderFrom=中华脑血管病杂志(电子版), authorId=0, author=, summary=对于心脏骤停患者，复苏后神经功能评估至关重要。准确的神经功能评估可以避免对于有脑复苏可能患者的过早或不恰当撤除生命支持手段而导致的不必要的死亡，也有助于早期识别无脑复苏希望的患者。, cover=https://img.medsci.cn/20211226/1640510284527_5579292.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Aug 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">对于心脏骤停患者，复苏后神经功能评估至关重要。准确的神经功能评估可以避免对于</span><span style="color: #333333;">有脑复苏可能患者的过早或不恰当撤除生命支持手段而导致的不必要的死亡，也有助于早期识别无脑</span><span style="color: #333333;">复苏希望的患者。我国心脏骤停后诊疗仍然存在诸多不足，如医务人员对复苏后神经功能评估的认知</span><span style="color: #333333;">度低、实践情况不规范等。为了提高院前急救、急诊科以及危重症医师对于心脏骤停后神经功能评估的</span><span style="color: #333333;">认知度，推进规范化神经功能评估操作流程，本文就《2020 年中国心脏骤停后脑保护专家共识》中的神经</span><span style="color: #333333;">功能评估部分进行解读，内容主要涉及心肺复苏后神经功能评估的手段和流程。</span></p>, tagList=[TagDto(tagId=885, tagName=心脏骤停), TagDto(tagId=11241, tagName=神经保护)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=11241, guiderKeyword=神经保护, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=168839, appHits=133, showAppHits=0, pcHits=1053, showPcHits=168703, likes=3, shares=19, comments=14, approvalStatus=1, publishedTime=Sun Dec 26 17:15:03 CST 2021, publishedTimeString=2021-08-20, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Dec 26 17:23:11 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 23:38:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《2020年中国心脏骤停后脑保护专家共识》解读一神经功能评估.pdf)])
《2020年中国心脏骤停后脑保护专家共识》解读一神经功能评估.pdf
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201584, encodeId=80ac1201584fb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8546546630, createdName=ms7000001245208170, createdTime=Thu Mar 10 23:32:46 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085270, encodeId=28fc10852e0b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Wed Dec 29 01:49:15 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084577, encodeId=2d9f10845e7ed, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Mon Dec 27 08:08:31 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084570, encodeId=7c6210845e062, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Dec 27 07:02:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084558, encodeId=eaa9108455891, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 05:32:03 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-03-10 ms7000001245208170

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1201584, encodeId=80ac1201584fb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8546546630, createdName=ms7000001245208170, createdTime=Thu Mar 10 23:32:46 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085270, encodeId=28fc10852e0b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Wed Dec 29 01:49:15 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084577, encodeId=2d9f10845e7ed, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Mon Dec 27 08:08:31 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084570, encodeId=7c6210845e062, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Dec 27 07:02:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084558, encodeId=eaa9108455891, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 05:32:03 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-29 Doctoryangbai

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1201584, encodeId=80ac1201584fb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8546546630, createdName=ms7000001245208170, createdTime=Thu Mar 10 23:32:46 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085270, encodeId=28fc10852e0b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Wed Dec 29 01:49:15 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084577, encodeId=2d9f10845e7ed, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Mon Dec 27 08:08:31 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084570, encodeId=7c6210845e062, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Dec 27 07:02:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084558, encodeId=eaa9108455891, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 05:32:03 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 滚蛋吧的肿瘤君

    ！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1201584, encodeId=80ac1201584fb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8546546630, createdName=ms7000001245208170, createdTime=Thu Mar 10 23:32:46 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085270, encodeId=28fc10852e0b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Wed Dec 29 01:49:15 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084577, encodeId=2d9f10845e7ed, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Mon Dec 27 08:08:31 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084570, encodeId=7c6210845e062, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Dec 27 07:02:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084558, encodeId=eaa9108455891, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 05:32:03 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1201584, encodeId=80ac1201584fb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8546546630, createdName=ms7000001245208170, createdTime=Thu Mar 10 23:32:46 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085270, encodeId=28fc10852e0b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Wed Dec 29 01:49:15 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084577, encodeId=2d9f10845e7ed, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Mon Dec 27 08:08:31 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084570, encodeId=7c6210845e062, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Dec 27 07:02:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084558, encodeId=eaa9108455891, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 05:32:03 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 ms1000001656413688

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

围手术期心脏骤停管理的临床实践建议

临床麻醉相关专家组（统称） · 2021-07-29

心脏骤停基层合理用药指南

中华医学会(CMA,Chinese Medical Association) · 2021-03-25

2021 ERC指南：特殊情况下的心脏骤停

欧洲复苏委员会(ERC,European Resuscitation Council) · 2021-03-30

2020 APHRS/HRS专家共识声明：不明原因猝死者，心脏骤停患者及其亲属的调查

亚太心律学会(APHRS,Asia Pacific Heart Rhythm Society) · 2020-10-13

2020 AHA科学声明：心脏骤停者存活

美国心脏协会(AHA,American Heart Association) · 2020-03-24

心脏骤停复苏后血流动力学管理的专家共识

中华医学会急诊医学分会 · 2019-11-30

拓展阅读

2019 SOGC临床实践指南：硫酸镁对胎儿的神经保护作用（No.376）

加拿大妇产科医生协会(SOGC,Society of Obstetricians and Gynaecologists of Canada) · 2019-03-20

Baidu
map
Baidu
map
Baidu
map